Brief: Herantis Pharma Says Covid-19 May Require Rescheduling Of Planned Treatments

Herantis Pharma Oyj

24/03/2020 07:03

March 24 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * HERANTIS PHARMA PLC ANNOUNCES CAPITAL MARKETS DAY WEBCAST
AND
PROVIDES UPDATE ON BUSINESS OPERATIONS DURING COVID-19
    * ON CORONAVIRUS: UPDATE ON ITS BUSINESS OPERATIONS DURING
COVID-19 (CORONAVIRUS) PANDEMIC.
    * COVID-19 OUTBREAK MAY REQUIRE RESCHEDULING OF SOME OF
PLANNED
TREATMENTS, COMPANY DOES NOT ANTICIPATE THAT SUCH CHANGES WILL
HAVE ANY MATERIAL IMPACT ON OUTCOMES OF THESE CLINICAL TRIALS.
    * DOES NOT CURRENTLY FORESEE ESSENTIAL IMPACT ON ITS PLANS,
AND
COMPANY'S PREVIOUSLY COMMUNICATED OUTLOOK FOR 2020 AND GUIDANCE
FOR 2020 REMAIN UNCHANGED

Source text for Eikon:  ID:nWkr5dhq5l 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))